| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |